GL1X · GenesisL1 explorer

MolNFT v1 · #143615 · protein

Ttk in complex with inhibitor

6B4W · Dual specificity protein kinase ttk: “Ttk in complex with inhibitor”. X-ray diffraction, 1 ligand (CQ7), 1 pocket (best druggability 0.79). MolNFT v1 #143615 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6B4W
Type
protein
Length
259 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dual specificity protein kinase ttk
EC
2.7.12.1
UniProt
P33981
Ligands
CQ7
Pockets
1 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADual specificity protein kinase ttk (EC 2.7.12.1)protein25937% helix, 20% strandP33981

Ligands and binding sites

  • CQ7 · 4-{[4-(cyclopentyloxy)-5-(2-methyl-1,3-benzoxazol-6-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino}-3-methoxy-N-methylbenzamide · ligand · chains A
  • CAC · Cacodylate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14050.790.8752CQ7

Compared structures

  • 6B4W · TTK in Complex with Inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.